A Japan-based global pharmaceutical manufacturer focused on developing and commercializing therapies for oncology, rare diseases, gastroenterology, and plasma-derived treatments. The company operates a large international footprint following its acquisition of Shire, with significant revenue exposur...
2 members of Congress have disclosed 11 trades in Takeda Pharmaceutical Company Limited (TAK), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2010-09-03 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2010-08-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2010-08-10 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2010-08-01 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2010-02-11 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2009-03-08 | DAVID DREIER | sell | $1K – $15K |
| 2008-12-11 | MICHAEL T. MCCAUL | sell | — |
| 2008-12-11 | MICHAEL T. MCCAUL | sell | — |
| 2008-09-09 | MICHAEL T. MCCAUL | sell | — |
| 2008-09-09 | MICHAEL T. MCCAUL | sell | — |
| 2003-03-10 | MICHAEL T. MCCAUL | buy | $15K – $50K |